Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

 129.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 137.50
  • 52 Week Low: 96.00
  • Currency: UK Pounds
  • Shares Issued: 104.77m
  • Volume: 52,695
  • Market Cap: £135.68m
  • RiskGrade: 81
  • Beta: 0.00

Cello Health injects pharma duo to board of directors

By Duncan Ferris

Date: Thursday 16 Aug 2018

LONDON (ShareCast) - (Sharecast News) - Healthcare advisory group Cello Health on Thursday appointed independent non-executive directors Clifford Tompsett and Jo LeCouilliard to its board of directors.
The move follows Paul Hamilton and Will David standing down as non-executive directors with immediate effect after both having served as members of the AIM traded company's board for more than a decade.

Mark Scott, chief executive of Cello, said: "I am delighted that the group has secured the services of two, highly experienced and capable new non-executive directors with deep experience across the pharmaceutical industry. The board very much looks forward to working with Clifford and Jo as we shape the future growth path for the group."

Tompsett was most recently a senior partner at PriceWaterhouseCoopers, where he held responsibility over the firm's global cross border IPO practice and led its UK and European activities in the pharmaceutical sector, and will head the audit committee and serve as senior independent director.

Meanwhile, LeCouilliard, who is currently a non-executive director of Circassia Pharmaceuticals, has held a number of senior positions in Asia and the US at GlaxoSmithKline, as well as at BMI Healthcare.

Cello's shares were up 0.77% at 131.50p at 1646 BST.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cello Health Market Data

Currency UK Pounds
Share Price 129.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 137.50
52 Week Low 96.00
Volume 52,695
Shares Issued 104.77m
Market Cap £135.68m
Beta 0.00
RiskGrade 81

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
69.97% below the market average69.97% below the market average69.97% below the market average69.97% below the market average69.97% below the market average
72.22% above the sector average72.22% above the sector average72.22% above the sector average72.22% above the sector average72.22% above the sector average
Price Trend
4.26% above the market average4.26% above the market average4.26% above the market average4.26% above the market average4.26% above the market average
5.00% above the sector average5.00% above the sector average5.00% above the sector average5.00% above the sector average5.00% above the sector average
Income
3.75% above the market average3.75% above the market average3.75% above the market average3.75% above the market average3.75% above the market average
57.14% above the sector average57.14% above the sector average57.14% above the sector average57.14% above the sector average57.14% above the sector average
Growth
33.25% below the market average33.25% below the market average33.25% below the market average33.25% below the market average33.25% below the market average
41.18% below the sector average41.18% below the sector average41.18% below the sector average41.18% below the sector average41.18% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  Interim Final
Ex-Div 03-Oct-19 25-Apr-19
Paid 01-Nov-19 24-May-19
Amount 1.15p 2.75p

Trades for 14-Oct-2019

Time Volume / Share Price
16:11 870 @ 128.03p
14:41 7,832 @ 128.18p
13:19 6,313 @ 128.18p
12:40 2,000 @ 128.18p
12:07 8,526 @ 128.81p

Cello Health Key Personnel

CEO Mark Scott

Top of Page